Chargari Cyrus

@supriyasastri @ACTREC_TMC @TataMemorial @RadOncTMC Great team and outstanding contribution to brachytherapy developments

📢📅L' #AFCOR_ organise une soirée virtuelle "Les Cas Pratiques de l'AFCOR sur l'Endomètre" le jeudi 17 mars 2022 de 19h00 à 20h00 avec @ChargariC et @AndresHuertasC1. Vous aurez les réponses à toutes vos questions ‼ Inscrivez-vous 👉afcor.fr/index.php/agen…

Residual distal parametrial involvement after radiochemotherapy is a true challenge for brachytherapists since the width and asymmetry of high-risk clinical target volume (HR-CTV) are difficult to cover properly with a standard implant. termedia.pl/Venezia-applic…

International Delphi consensus for pelvic Stereotactic Ablative Radiotherapy reirradiation -> important field of research due to more effective systemic therapy and consequential need to achieve long-term tumor control instead of short-term palliation sciencedirect.com/science/articl…

Major study that should change standard in metastatic and recurrent cervical cancer patients. Next step is to reduce systemic recurrence rate in locally advanced setting. We hope ongoing trials combining CRT with immunotherapy will also translate into benefits for patients!

KEYNOTE 826 : Bénéfice en PFS et en OS pour le pembrolizumab en association avec la chimiothérapie + bevacizumab #cervicalcancer #ESMO21 @NEJM @OncoClic

#High-#frequency #ultrasound #HFUS supports diagnosis and management of #skincancer. Provides essential information on tumors’ size, margins, and the depth of invasion. Highly recommended #educationalarticle! termedia.pl/The-use-of-hig… #ThisIsBrachytherapy #HFUS #EduArt